NANOVIRICIDES, INC.

For the period ended Jun 30, 2025. Filed Sep 29, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Sep 29, 2025

NNVC$1.42+6.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets at June 30, 2025 and 2024

Balance Sheet


	June 30, 2025		June 30, 2024

ASSETS · ·
CURRENT ASSETS: · ·
Cash and cash equivalents		$1,558,564		$4,797,778
Prepaid expenses		112,146		172,742
Total current assets		1,670,710		4,970,520

Property and equipment, net		6,833,891		7,512,463

Intangible assets, net		317,039		325,308

OTHER ASSETS
Service agreements		2,445		14,562

Total assets		$8,824,085		$12,822,853

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable		$459,094		$376,270
Accounts payable – related party		821,456		720,039
Accrued expenses		25,969		262,467
Total current liabilities		1,306,519		1,358,776

COMMITMENTS AND CONTINGENCIES (NOTE 11)

STOCKHOLDERS’ EQUITY:
Series A convertible preferred stock, $0.00001 par value, 10,000,000 shares designated, 905,717 and 892,625 shares issued and outstanding, at June 30, 2025 and 2024, respectively. (Note 9)		9		9
Common stock, $0.00001 par value; 150,000,000 shares authorized, 16,606,832 and 13,144,055 shares issued and outstanding at June 30, 2025 and 2024, respectively. (Note 8)		166		131
Additional paid-in capital		156,359,252		150,838,832
Accumulated deficit		(148,841,861)		(139,374,895)
Total stockholders’ equity		7,517,566		11,464,077
Total liabilities and stockholders’ equity		$8,824,085		$12,822,853

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.